SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 46 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $119,983 | +1.8% | 120,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $117,900 | +1.6% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $116,000 | 0.0% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $116,000 | -1.7% | 120,000 | 0.0% | 0.00% | – |
| Q1 2022 | $118,000 | 0.0% | 120,000 | 0.0% | 0.00% | – |
| Q4 2021 | $118,000 | 0.0% | 120,000 | 0.0% | 0.00% | – |
| Q3 2021 | $118,000 | 0.0% | 120,000 | 0.0% | 0.00% | – |
| Q2 2021 | $118,000 | +1.7% | 120,000 | 0.0% | 0.00% | – |
| Q1 2021 | $116,000 | +1.8% | 120,000 | 0.0% | 0.00% | – |
| Q4 2020 | $114,000 | +2.7% | 120,000 | 0.0% | 0.00% | – |
| Q3 2020 | $111,000 | +4.7% | 120,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $106,000 | +10.4% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $96,000 | -11.9% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $109,000 | – | 120,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 45,402,000 | $45,147,000 | 3.42% |
| Ayrton Capital LLC | 2,000,000 | $1,982,000 | 1.87% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $68,018,000 | 1.78% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 74,027,000 | $73,675,000 | 1.54% |
| DeepCurrents Investment Group LLC | 33,182,000 | $32,736,000 | 1.02% |
| Penn Mutual Asset Management | 675 | $665,000 | 0.71% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,897,000 | $7,533,000 | 0.51% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,901,000 | $19,714,000 | 0.22% |
| WOLVERINE ASSET MANAGEMENT LLC | 9,940,000 | $9,858,000 | 0.09% |
| Jefferies Group LLC | 12,740,000 | $12,658,285 | 0.07% |